Endocannabinoids in the new millenniumDI MARZO, Vincenzo.Prostaglandins, leukotrienes and essential fatty acids. 2002, Vol 66, Num 2-3, issn 0952-3278, 302 p.Serial Issue

CB₁ receptor antagonism: biological basis for metabolic effectsDI MARZO, Vincenzo.Drug discovery today. 2008, Vol 13, Num 23-24, pp 1026-1041, issn 1359-6446, 16 p.Article

Endocannabinoids and the control of energy balanceMATIAS, Isabel; DI MARZO, Vincenzo.Trends in endocrinology and metabolism. 2007, Vol 18, Num 1, pp 27-37, issn 1043-2760, 11 p.Article

Discovery of endocannabinoids and some random thoughts on their possible roles in neuroprotection and aggressionMECHOULAM, R.Prostaglandins, leukotrienes and essential fatty acids. 2002, Vol 66, Num 2-3, pp 93-99, issn 0952-3278Article

New perspectives on enigmatic vanilloid receptorsSZALLASI, Arpad; DI MARZO, Vincenzo.Trends in neurosciences (Regular edition). 2000, Vol 23, Num 10, pp 491-497, issn 0166-2236Article

Molecular biology of cannabinoid receptorsLUTZ, B.Prostaglandins, leukotrienes and essential fatty acids. 2002, Vol 66, Num 2-3, pp 123-142, issn 0952-3278Article

Endocannabinoids in the central nervous system: an overviewFRIDE, E.Prostaglandins, leukotrienes and essential fatty acids. 2002, Vol 66, Num 2-3, pp 221-233, issn 0952-3278Article

Endocannabinoids and neuropathic pain: focus on neuron-glia and endocannabinoid-neurotrophin interactions : NEUROBIOLOGY OF PAINLUONGO, Livio; MAIONE, Sabatino; DI MARZO, Vincenzo et al.European journal of neuroscience (Print). 2014, Vol 39, Num 3-4, pp 401-408, issn 0953-816X, 8 p.Article

Endocannabinoids: A unique opportunity to develop multitarget analgesicsMAIONE, Sabatino; COSTA, Barbara; DI MARZO, Vincenzo et al.Pain (Amsterdam). 2013, Vol 154, issn 0304-3959, S87-S93, SUP1Article

CB₁ and CB₂ receptor-mediated signalling: a focus on endocannabinoidsMCALLISTER, Sean D; GLASS, Michelle.Prostaglandins, leukotrienes and essential fatty acids. 2002, Vol 66, Num 2-3, pp 161-171, issn 0952-3278Article

TRPV1 Receptors in the Central Nervous System : Potential for Previously Unforeseen Therapeutic Applications : New potential therapies from vanilloid transient receptor cation (TRPV) channelsSTAROWICZ, Katarzyna; CRISTINO, Luigia; DI MARZO, Vincenzo et al.Current pharmaceutical design. 2008, Vol 14, Num 1, pp 42-54, issn 1381-6128, 13 p.Article

Endocannabinoid structure-activity relationships for interaction at the cannabinoid receptorsREGGIO, P. H.Prostaglandins, leukotrienes and essential fatty acids. 2002, Vol 66, Num 2-3, pp 143-160, issn 0952-3278Article

The endocannabinoid system: a general view and latest additionsDE PETROCELLIS, Luciano; CASCIO, Maria Grazia; DI MARZO, Vincenzo et al.British journal of pharmacology. 2004, Vol 141, Num 5, pp 765-774, issn 0007-1188, 10 p.Article

Synthesis of a potential photoactivatable anandamide analogBALAS, Laurence; GRAZIA CASCIO, Maria; DI MARZO, Vincenzo et al.Bioorganic & medicinal chemistry letters (Print). 2006, Vol 16, Num 14, pp 3765-3768, issn 0960-894X, 4 p.Article

Endocannabinoids, food intake and body weightMATIAS, Isabel; DI MARZO, Vincenzo.Recent advances in pharmacology and physiology of cannabinoids 2004. 2004, pp 217-236, isbn 81-271-0052-8, 20 p.Book Chapter

Cannabinoid receptor-inactive N-acylethanolamines and other fatty acid amides: metabolism and functionSCHMID, H. H. O; BERDYSHEV, E. V.Prostaglandins, leukotrienes and essential fatty acids. 2002, Vol 66, Num 2-3, pp 363-376, issn 0952-3278Article

Lipidomic methodologies applicable to the study of endocannabinoids and related compounds : EndocannabinoidomicsBISOGNO, Tiziana; PISCITELLI, Fabiana; DI MARZO, Vincenzo et al.European journal of lipid science and technology (Print). 2009, Vol 111, Num 1, pp 53-63, issn 1438-7697, 11 p.Article

Cellular transport of anandamide, 2-arachidonoylglycerol and palmitoylethanolamide-targets for drug development?FOWLER, C. J; JACOBSSON, S. O. P.Prostaglandins, leukotrienes and essential fatty acids. 2002, Vol 66, Num 2-3, pp 193-200, issn 0952-3278Article

Endocannabinoids in pain modulationWALKER, J. M; HUANG, S. M.Prostaglandins, leukotrienes and essential fatty acids. 2002, Vol 66, Num 2-3, pp 235-242, issn 0952-3278Article

Neuromodulatory role of the endocannabinoid signaling system in alcoholism: an overviewBASAVARAJAPPA, B. S; HUNGUND, B. L.Prostaglandins, leukotrienes and essential fatty acids. 2002, Vol 66, Num 2-3, pp 287-299, issn 0952-3278Article

Cardiovascular pharmacology of anandamideHÖGESTÄTT, E. D; ZYGMUNT, P. M.Prostaglandins, leukotrienes and essential fatty acids. 2002, Vol 66, Num 2-3, pp 343-351, issn 0952-3278Article

Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosaMONTELEONE, Palmiero; MATIAS, Isabelle; MARTIADIS, Vassilis et al.Neuropsychopharmacology (New York, NY). 2005, Vol 30, Num 6, pp 1216-1221, issn 0893-133X, 6 p.Article

The anandamide membrane transporter. Structure-activity relationships of anandamide and oleoylethanolamine analogs with phenyl rings in the polar head group regionDI MARZO, Vincenzo; LIGRESTI, Alessia; MORERA, Enrico et al.Bioorganic & medicinal chemistry. 2004, Vol 12, Num 19, pp 5161-5169, issn 0968-0896, 9 p.Article

Novel selective and metabolically stable inhibitors of anandamide cellular uptakeORTAR, Giorgio; LIGRESTI, Alessia; DE PETROCELLIS, Luciano et al.Biochemical pharmacology. 2003, Vol 65, Num 9, pp 1473-1481, issn 0006-2952, 9 p.Article

Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathyRICE, A. S. C; FARQUHAR-SMITH, W. P; NAGY, I et al.Prostaglandins, leukotrienes and essential fatty acids. 2002, Vol 66, Num 2-3, pp 243-256, issn 0952-3278Article